Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Zoé LE van Kempen"'
Autor:
Niels JM Verstegen, Ruth R Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas Ashhurst, Laura YL Kummer, Maurice Steenhuis, Mariel Duurland, Rivka de Jongh, Nina de Jong, C Ellen van der Schoot, Amélie V Bos, Erik Mul, Katherine Kedzierska, Koos PJ van Dam, Eileen W Stalman, Laura Boekel, Gertjan Wolbink, Sander W Tas, Joep Killestein, Zoé LE van Kempen, Luuk Wieske, Taco W Kuijpers, Filip Eftimov, Theo Rispens, S Marieke van Ham, Anja ten Brinke, Carolien E van de Sandt, On behalf of the T2B! immunity against SARS-CoV-2 study group
Publikováno v:
eLife, Vol 11 (2022)
Background: Patients affected by different types of autoimmune diseases, including common conditions such as multiple sclerosis (MS) and rheumatoid arthritis (RA), are often treated with immunosuppressants to suppress disease activity. It is not full
Externí odkaz:
https://doaj.org/article/731224c95d814455a088b97c4f3d1a9f
Autor:
Zoë YGJ van Lierop, Samantha Noteboom, Martijn D Steenwijk, Maureen van Dam, Alyssa A Toorop, Zoé LE van Kempen, Bastiaan Moraal, Frederik Barkhof, Bernard MJ Uitdehaag, Menno M Schoonheim, Charlotte E Teunissen, Joep Killestein
Publikováno v:
Multiple Sclerosis Journal, 28(14), 2231-2242. SAGE Publications Ltd
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
van Lierop, Z Y GJ, Noteboom, S, Steenwijk, M D, van Dam, M, Toorop, A A, van Kempen, Z L E, Moraal, B, Barkhof, F, Uitdehaag, B M J, Schoonheim, M M, Teunissen, C E & Killestein, J 2022, ' Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis ', Multiple Sclerosis Journal, vol. 28, no. 14, pp. 2231-2242 . https://doi.org/10.1177/13524585221118676
Background: Despite highly effective treatment strategies for patients with relapsing-remitting multiple sclerosis (RRMS), long-term neurodegeneration and disease progression are often considerable. Accurate blood-based biomarkers that predict long-t
Autor:
Niels JM Verstegen, Ruth R Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas Ashhurst, Laura YL Kummer, Maurice Steenhuis, Mariel Duurland, Rivka de Jongh, Nina de Jong, C Ellen van der Schoot, Amélie V Bos, Erik Mul, Katherine Kedzierska, Koos PJ van Dam, Eileen W Stalman, Laura Boekel, Gertjan Wolbink, Sander W Tas, Joep Killestein, Zoé LE van Kempen, Luuk Wieske, Taco W Kuijpers, Filip Eftimov, Theo Rispens, S Marieke van Ham, Anja ten Brinke, Carolien E van de Sandt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54e02ead6429d1677d91c7bb014cffd7
https://doi.org/10.7554/elife.77969.sa2
https://doi.org/10.7554/elife.77969.sa2
Publikováno v:
van Kempen, Z L E, Hogenboom, L & Killestein, J 2022, ' Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing : NO ', Multiple Sclerosis Journal, vol. 28, no. 5, pp. 693-695 . https://doi.org/10.1177/13524585211064441
Multiple Sclerosis Journal, 28(5), 693-695. SAGE Publications Ltd
Multiple Sclerosis Journal, 28(5), 693-695. SAGE Publications Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f4b5310f8999437fd2219511d83f79
https://research.vumc.nl/en/publications/7d39ae10-2ccf-4e70-93b6-e0e4eb0261a5
https://research.vumc.nl/en/publications/7d39ae10-2ccf-4e70-93b6-e0e4eb0261a5
Autor:
Alyssa A Toorop, Maurice Steenhuis, Floris C Loeff, Suzanne S Weijers, Joep Killestein, Theo Rispens, Zoé LE van Kempen
Publikováno v:
Multiple Sclerosis Journal. SAGE Publications Ltd
Toorop, A A, Steenhuis, M, Loeff, F C, Weijers, S S, Killestein, J, Rispens, T & Kempen, Z L E V 2022, ' Fingerprick blood samples to measure serum natalizumab concentrations ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585221136448
Toorop, A A, Steenhuis, M, Loeff, F C, Weijers, S S, Killestein, J, Rispens, T & Kempen, Z L E V 2022, ' Fingerprick blood samples to measure serum natalizumab concentrations ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585221136448
Background: Natalizumab via subcutaneous administration was recently approved for patients with multiple sclerosis. Objective: In light of personalized extended dosing, in which treatment intervals are prolonged to a concentration cut-off, it would b
Publikováno v:
van Kempen, Z L E, Toorop, A A, Sellebjerg, F, Giovannoni, G & Killestein, J 2021, ' Extended dosing of monoclonal antibodies in multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211065711
Over the past two decades, treatment options for patients with multiple sclerosis (MS) have increased exponentially. In the current therapeutic landscape, “no evidence of MS disease activity” is within reach in many of our patients. Minimizing ri
Autor:
Alyssa A Toorop, Theo Rispens, Eva MM Strijbis, Bob W van Oosten, Brigit A de Jong, Bernard MJ Uitdehaag, Joep Killestein, Zoé LE van Kempen
Publikováno v:
Multiple Sclerosis Journal. SAGE Publications Ltd
Multiple Sclerosis (Houndmills, Basingstoke, England)
Toorop, A A, Rispens, T, Strijbis, E M M, van Oosten, B W, de Jong, B A, Uitdehaag, B M J, Killestein, J & van Kempen, Z L E 2021, ' Natalizumab concentrations during pregnancy in three patients with multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211052168
Multiple Sclerosis (Houndmills, Basingstoke, England)
Toorop, A A, Rispens, T, Strijbis, E M M, van Oosten, B W, de Jong, B A, Uitdehaag, B M J, Killestein, J & van Kempen, Z L E 2021, ' Natalizumab concentrations during pregnancy in three patients with multiple sclerosis ', Multiple Sclerosis Journal . https://doi.org/10.1177/13524585211052168
In women with very active multiple sclerosis (MS), natalizumab can be continued during pregnancy to prevent rebound disease activity. Our aim was to evaluate changes in serum natalizumab trough concentrations during pregnancy. Blood samples of 3 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9910ddf91621ae7cc01668a003aba1d5
https://research.vumc.nl/en/publications/fa1b4359-5857-4374-a72c-f2045a280df4
https://research.vumc.nl/en/publications/fa1b4359-5857-4374-a72c-f2045a280df4